WallStreetZenWallStreetZen

NASDAQ: CADL
Candel Therapeutics Inc Stock Ownership - Who owns Candel Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Candel Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Jason AmelloChief Financial Officer2023-11-2820,153$0.90
$18.14kSell
Francesca BaroneChief Scientific Officer2023-11-2819,748$0.90
$17.77kSell
William Garrett NicholsChief Medical Officer2023-11-2812,175$0.90
$10.96kSell
Paul Peter TakChief Executive Officer2023-11-2843,443$0.90
$39.10kSell
Seshu TyagarajanChief Technology Officer2023-11-2817,328$0.90
$15.60kSell

1 of 1

CADL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CADL insiders and whales buy or sell their stock.

CADL Shareholders

What type of owners hold Candel Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Estuardo Aguilarcordova10.81%3,171,974$17.26MInsider
Laura K. Aguilar10.38%3,046,940$16.58MInsider
Paul B. Manning9.93%2,913,910$15.85MInsider
Northpond Ventures LLC6.59%1,935,215$10.53MInstitution
Sands Capital Ventures LLC2.77%811,737$4.42MInstitution
Christopher Martell2.00%587,514$3.20MInsider
Vanguard Group Inc1.45%425,749$2.32MInstitution
Paul Peter Tak1.27%373,556$2.03MInsider
Fmr LLC1.02%298,384$1.62MInstitution
Jason Amello0.69%202,009$1.10MInsider

1 of 3

CADL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CADL13.72%37.54%Net Selling
ZURA27.84%72.16%Net Selling
INMB12.71%40.17%Net Selling
CAPR11.25%88.75%Net Buying
SCPH56.17%43.83%Net Selling
View Top Biotech Stocks

Candel Therapeutics Stock Ownership FAQ

Who owns Candel Therapeutics?

Candel Therapeutics (NASDAQ: CADL) is owned by 13.72% institutional shareholders, 37.54% Candel Therapeutics insiders, and 48.74% retail investors. Estuardo Aguilarcordova is the largest individual Candel Therapeutics shareholder, owning 3.17M shares representing 10.81% of the company. Estuardo Aguilarcordova's Candel Therapeutics shares are currently valued at $17.32M.

If you're new to stock investing, here's how to buy Candel Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.